ORAMED PHARMACEUTICALS INC. Quarterly Marketable Securities, Current in USD from Q3 2011 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Oramed Pharmaceuticals Inc. quarterly Marketable Securities, Current history and growth rate from Q3 2011 to Q2 2024.
  • Oramed Pharmaceuticals Inc. Marketable Securities, Current for the quarter ending June 30, 2024 was $2.35M, a 149% increase year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $2.35M +$1.4M +149% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $2.03M -$241K -10.6% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $1.81M -$1.94M -51.7% Dec 31, 2023 10-Q 2024-08-14
Q2 2023 $943K -$5.68M -85.8% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $2.27M -$5.01M -68.8% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $3.74M -$4M -51.7% Dec 31, 2022 10-K 2024-03-06
Q3 2022 $5.23M -$617K -10.5% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $6.63M -$585K -8.11% Jun 30, 2022 10-Q 2022-08-10
Q1 2022 $7.28M -$2.59M -26.3% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $7.75M -$1.08M -12.2% Dec 31, 2021 10-K 2023-03-06
Q3 2021 $5.85M -$3.69M -38.7% Aug 31, 2021 10-QT 2022-03-30
Q2 2021 $7.21M -$1.13M -13.5% May 31, 2021 10-Q 2021-07-14
Q1 2021 $9.87M +$4.16M +73% Feb 28, 2021 10-Q 2021-04-13
Q4 2020 $8.83M +$5.62M +175% Nov 30, 2020 10-Q 2021-01-14
Q3 2020 $9.54M +$5.84M +158% Aug 31, 2020 10-K 2021-11-24
Q2 2020 $8.34M +$4.11M +97.4% May 31, 2020 10-Q 2020-07-07
Q1 2020 $5.7M +$230K +4.2% Feb 29, 2020 10-Q 2020-04-06
Q4 2019 $3.21M -$1.94M -37.6% Nov 30, 2019 10-Q 2020-01-09
Q3 2019 $3.7M -$891K -19.4% Aug 31, 2019 10-K 2020-11-24
Q2 2019 $4.22M +$513K +13.8% May 31, 2019 10-Q 2019-07-10
Q1 2019 $5.47M +$2.25M +69.5% Feb 28, 2019 10-Q 2019-04-10
Q4 2018 $5.14M +$2.42M +88.9% Nov 30, 2018 10-Q 2019-01-14
Q3 2018 $4.59M +$1.73M +60.6% Aug 31, 2018 10-K 2019-11-27
Q2 2018 $3.71M +$638K +20.8% May 31, 2018 10-Q 2018-07-12
Q1 2018 $3.23M -$378K -10.5% Feb 28, 2018 10-Q 2018-04-09
Q4 2017 $2.72M -$968K -26.2% Nov 30, 2017 10-Q 2018-01-11
Q3 2017 $2.86M +$5K +0.18% Aug 31, 2017 10-K 2018-11-28
Q2 2017 $3.07M -$291K -8.65% May 31, 2017 10-Q 2017-07-06
Q1 2017 $3.61M +$1.53M +73.3% Feb 28, 2017 10-Q 2017-04-05
Q4 2016 $3.69M +$1.71M +86% Nov 30, 2016 10-Q 2017-01-11
Q3 2016 $2.86M +$767K +36.7% Aug 31, 2016 10-K 2017-11-29
Q2 2016 $3.36M +$2.61M +344% May 31, 2016 10-Q 2016-07-06
Q1 2016 $2.08M +$1.39M +199% Feb 29, 2016 10-Q 2016-04-06
Q4 2015 $1.98M +$1.3M +188% Nov 30, 2015 10-Q 2016-01-13
Q3 2015 $2.09M +$1.04M +99.4% Aug 31, 2015 10-K 2016-11-25
Q2 2015 $758K -$305K -28.7% May 31, 2015 10-Q 2015-07-01
Q1 2015 $695K -$769K -52.5% Feb 28, 2015 10-Q 2015-04-03
Q4 2014 $688K -$274K -28.5% Nov 30, 2014 10-Q 2015-01-08
Q3 2014 $1.05M +$91K +9.52% Aug 31, 2014 10-K 2015-11-25
Q2 2014 $1.06M +$260K +32.4% May 31, 2014 10-Q 2014-07-14
Q1 2014 $1.46M +$477K +48.3% Feb 28, 2014 10-Q 2014-04-10
Q4 2013 $962K -$102K -9.62% Nov 30, 2013 10-Q 2014-01-14
Q3 2013 $956K +$756K +377% Aug 31, 2013 10-K 2014-11-14
Q2 2013 $803K +$446K +125% May 31, 2013 10-Q 2013-07-17
Q1 2013 $987K +$646K +189% Feb 28, 2013 10-Q 2013-04-11
Q4 2012 $1.06M +$684K +180% Nov 30, 2012 10-Q 2012-12-26
Q3 2012 $200K -$184K -47.9% Aug 31, 2012 10-K 2013-11-27
Q2 2012 $357K May 31, 2012 10-Q 2012-07-12
Q1 2012 $341K Feb 29, 2012 10-Q 2012-04-04
Q4 2011 $380K Nov 30, 2011 10-Q 2012-01-12
Q3 2011 $385K Aug 31, 2011 10-K 2012-12-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.